Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SANUWAVE Health (SNWV) Non-Current Deffered Revenue (2018 - 2026)

SANUWAVE Health has reported Non-Current Deffered Revenue over the past 9 years, most recently at $676000.0 for Q1 2026.

  • Quarterly Non-Current Deffered Revenue rose 111.91% to $676000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $676000.0 through Mar 2026, up 111.91% year-over-year, with the annual reading at $701000.0 for FY2025, 133.67% up from the prior year.
  • Non-Current Deffered Revenue was $676000.0 for Q1 2026 at SANUWAVE Health, down from $701000.0 in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $701000.0 in Q4 2025 and troughed at $205000.0 in Q3 2022.
  • The 5-year median for Non-Current Deffered Revenue is $319000.0 (2025), against an average of $360764.7.
  • Year-over-year, Non-Current Deffered Revenue dropped 27.12% in 2023 and then surged 133.67% in 2025.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $230000.0 in 2022, then surged by 50.87% to $347000.0 in 2023, then dropped by 13.54% to $300000.0 in 2024, then surged by 133.67% to $701000.0 in 2025, then dropped by 3.57% to $676000.0 in 2026.
  • Per Business Quant, the three most recent readings for SNWV's Non-Current Deffered Revenue are $676000.0 (Q1 2026), $701000.0 (Q4 2025), and $575000.0 (Q3 2025).